ArticleRSC advances2021

A novel route to size-controlled MIL-53(Fe) metal-organic frameworks for combined chemodynamic therapy and chemotherapy for cancer.

Anxia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.